| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 13,100 | $30 | $340.7K |
| J9312 | Injection, rituximab, 10 mg | 3,900 | $60 | $245.7K |
| J3262 | Injection, tocilizumab, 1 mg | 34,440 | $10 | $172.2K |
| J0897 | Injection, denosumab, 1 mg | 6,180 | $20 | $117.4K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 11,550 | $10 | $115.5K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 570 | $130 | $72.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 560 | $90 | $49K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 340 | $110 | $35.6K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 200 | $50 | $10.3K |
| 86235 | The lab analyst performs an assay to evaluate the patient’s serum for each antibody to an extractable nuclear antigen, also called ENA. Types of ENA antibodies include anti ribonuclear protein,… | 430 | $20 | $7.8K |